Articles
-
Putting More Within Reach
3/16/2026
A wearable subcutaneous injector is being developed to support delivery of large‑volume, complex biologic therapies, expanding options for patients needing advanced at‑home administration.
-
BD Neopak™ XtraFlow™ Glass Prefillable Syringe
3/16/2026
A next‑generation injectable system uses shorter, thinner needles to reduce injection risk, lower force and time requirements, and improve comfort and usability for administering viscous formulations.
-
A Smooth Transition To USP <382> With Established Expertise
3/16/2026
A new regulatory chapter requires holistic, real‑world testing of injectable systems, mandating full‑system validation with actual drug products and prioritizing patient‑centric performance and safety.
-
An Integrated, Verified PFS System For Vaccines
2/23/2026
A pre-verified delivery platform eliminates redundant testing, simplifies regulatory submissions, and optimizes inventory management, allowing teams to focus on drug-specific performance.
-
Freeze Your Device Design With An Integrated, Verified PFA System
2/23/2026
Leverage a pre-verified, integrated syringe platform. Accelerate timelines and reduce costs by eliminating drug-independent testing while streamlining regulatory submissions through one source.
-
De-Risk Your Combination Product Development
2/23/2026
Adopting a unified, pre-verified drug delivery system streamlines performance testing and data management, ensuring developers reach critical clinical milestones with greater speed.
-
Sterile Drug Product
2/4/2026
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
-
Meet The Demands Of Today To Help Ensure The Possibility Of Tomorrow
2/2/2026
Emergency‑readiness programs strengthen response with dependable countermeasures, rapid‑action tools, and decades of expertise supporting teams facing chemical, biological, and other high‑risk threats.
-
A Comprehensive Approach That's Exceptional By Design
2/2/2026
An overview of analytical capabilities to boost product quality, meet regulatory expectations, and drive development through phase‑appropriate methods and specialized testing for complex drug programs.
-
Bridgeton – Our World Class Fill Finish Facility
2/2/2026
A scalable aseptic environment for diverse injectables, advanced automation, and Annex 1–aligned processes, supporting smooth transitions from development to commercial supply and long‑term strategy.